Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  SEEDMAN MICHAEL
 2. Date of Event Requiring Statement (Month/Day/Year)
02/04/2011		 3. Issuer Name and Ticker or Trading Symbol
MedQuist Holdings Inc. [MEDH]
(Last)
(First)
(Middle)
C/O MEDQUIST HOLDINGS INC., 9009 CAROTHERS PARKWAY		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Chief Technology Officer
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

FRANKLIN, TN 37067		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (Right to Buy)   (1) 08/06/2018 Common Stock 242,044 $ 5.01 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
SEEDMAN MICHAEL
C/O MEDQUIST HOLDINGS INC.
9009 CAROTHERS PARKWAY
FRANKLIN, TN 37067		   X     Chief Technology Officer  

Signatures

/s/ Mark Sullivan, Authorized Signatory 02/04/2011
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Represents options to purchase the common stock of MedQuist Holdings Inc. which are subject to the following vesting schedule: one-third of the shares vested on August 6, 2009, and one-sixth of the shares vest every six months thereafter.
 
Remarks:
Mr. Seedman is a director and Chief Technology Officer of MedQuist Holdings Inc.  Mr. Seedman also serves as an executive partner, a
senior operating consultant role, to S.A.C. Private Capital Group, LLC, affiliates of which, S.A.C. PEI CB Investment, L.P. ("SAC
CBI"), S.A.C. PEI CB Investment II, LLC ("SAC CBI II") and International Equities (S.A.C. Asia) Limited ("SAC
Asia"), hold shares of MedQuist Holdings Inc. common stock.  Mr. Seedman disclaims beneficial ownership of the shares of MedQuist
Holdings Inc. owned by SAC CBI, SAC CBI II and SAC Asia, and this report shall not be deemed an admission that Mr. Seedman is the
beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other
purpose.

Exhibit List:  Exhibit 24 - Power of Attorney

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.